*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : XI0389900
CHEMICAL NAME : 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic
acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)
thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-
CAS REGISTRY NUMBER : 25953-19-9
BEILSTEIN REFERENCE NO. : 4169371
LAST UPDATED : 199612
DATA ITEMS CITED : 7
MOLECULAR FORMULA : C14-H14-N8-O4-S3
MOLECULAR WEIGHT : 454.54
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* Cefamezin
* Cefazolin
* Cefazoline
* Cephamezine
* Cephazolin
* Cephazoline
* CEZ
* Elzogram
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BYYADW Byoin Yakugaku. Hospital Pharmacology. (Yakuji Nippon Sha, 1-11
Izumi-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1975-
Volume(issue)/page/year: 3,220,1978
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intramuscular
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BYYADW Byoin Yakugaku. Hospital Pharmacology. (Yakuji Nippon Sha, 1-11
Izumi-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1975-
Volume(issue)/page/year: 3,220,1978
** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 164 gm/kg/26W-I
TOXIC EFFECTS :
Blood - normocytic anemia
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - transaminases
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
28(Suppl 7),1089,1980
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 44100 mg/kg/35D-I
TOXIC EFFECTS :
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - transaminases
Related to Chronic Data - death
REFERENCE :
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki,
Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year:
28(Suppl 7),1007,1980
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 11200 mg/kg/28D-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in tubules (including acute renal failure,
acute tubular necrosis)
REFERENCE :
BYYADW Byoin Yakugaku. Hospital Pharmacology. (Yakuji Nippon Sha, 1-11
Izumi-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1975-
Volume(issue)/page/year: 3,220,1978
*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***
NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOHS - National Occupational Hazard Survey (1974)
NOHS Hazard Code - A1317
No. of Facilities: 33 (estimated)
No. of Industries: 1
No. of Occupations: 1
No. of Employees: 528 (estimated)
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - A1317
No. of Facilities: 318 (estimated)
No. of Industries: 1
No. of Occupations: 5
No. of Employees: 16111 (estimated)
No. of Female Employees: 13596 (estimated)
*** END OF RECORD ***
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
5-Thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylicacid, 3-(hydroxymethyl)-8-oxo-7-(2-(4-pyridylthio)acetamido)-, acetate (ester), monosodiumsalt
| 24356-60-3 |
2-Thenylamine, N,N-bis(2-chloroethyl)-5-methyl-
| 3331-95-1 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate (ester)
| 153-61-7 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate, monosodium salt
| 58-71-9 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, sodium salt
| 5547-29-5 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((((4-hydroxy-6-methyl-3-pyridinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-t etrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt,(6R-(6-alpha,7-beta(R*)))-
| 74849-93-7 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-((hydroxyphenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-,(6R-(6-alpha,7-beta(R*)))-
| 34444-01-4 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid,7-((hydroxyphenylacetyl)amino)-8-oxo-3-(((1-sulfomethyl)-1H-tetrazol-5-yl) thio)methyl)-,(6R-(6-alpha,7-beta(R*)))-
| 61270-58-4 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((((5-hydroxy-2-(1-piperazinyl)pyrido(2,3-d)pyrimidin-6-yl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)- 3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodium salt,(6R-(6-alpha,7-beta(R*)))-
| 60837-22-1 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-((((1-imino-2-phenylethyl)amino)acetyl)amino)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-, (6R-trans)-
| 40158-24-5 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, monosodiumsalt, D-
| 30034-03-8 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(4-methoxyphenyl)cyclopentyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)-
| 108098-26-6 |
2-Thenylamine, N,N-bis(2-chloroethyl)-5-methyl-,hydrochloride
| 14742-54-2 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(3-methoxyphenyl)cyclopropyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)-
| 108098-17-5 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(4-methoxyphenyl)cyclopropyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)-
| 108098-18-6 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-methyl-8-oxo-7-(((1-phenylcyclopentyl)carbonyl)amino)-,(6R-trans)-
| 108098-25-5 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-methyl-8-oxo-7-(((1-phenylcyclopropyl)carbonyl)amino)-,(6R-trans)-
| 108098-16-4 |
5-Thia-1-azabicyclo(4,2,0)oct-2-ene-2-carboxylicacid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-(6R,7R)-7-(2-(3,5-dichloro-4-oxo-1(4H)-pyridyl)acetamid o)-, monosodium salt
| 63521-15-3 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-
| 25953-19-9 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-, mixed with sodium nitrite (1:4)
| 25953-19-9 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, (6R-trans)-, sodium salt
| 27164-46-1 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 8-oxo-7-((1H-tetrazol-1-ylacetyl)amino)-3-((1,3,4-thiadiazol-2-ylthio)methyl)-,monosodium salt, (6R-trans)-
| 41136-22-5 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(4-propoxyphenyl)cyclobutyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)-
| 108098-22-2 |
Tetrodotoxin, O(sup 4)-methyl-
| 7724-39-2 |
2-Thenylamine, alpha-(p-bromobenzyl)-, hydrochloride
| 80154-75-2 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(2-propoxyphenyl)cyclopentyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)-
| 108098-30-2 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(3-propoxyphenyl)cyclopentyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)-
| 108098-29-9 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(4-propoxyphenyl)cyclopentyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)-
| 108098-28-8 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(2-propoxyphenyl)cyclopropyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)-
| 108098-20-0 |
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid, 7-(((1-(4-propoxyphenyl)cyclopropyl)carbonyl)amino)-3-methyl-8-oxo-, (6R-trans)-
| 108146-11-8 |
1-Thia-3-aza-2-silacyclopentane,2-(p-chlorophenyl)-2,5-diphenyl-
| 102367-62-4 |
1-Thia-3-aza-2-silacyclopentane,2-(p-chlorophenyl)-2-methyl-
| 84260-43-5 |
1-Thia-3-aza-2-silacyclopentane, 2,2-diethyl-
| 84260-21-9 |
1-Thia-3-aza-2-silacyclopentane,2,2-diethyl-5-methyl-
| 84260-33-3 |
1-Thia-3-aza-2-silacylcopentane, 2,2-dimethyl-
| 84260-28-6 |
2-Thenylamine, alpha-(p-bromobenzyl)-N-isopropyl-,hydrochloride
| 80154-76-3 |
1-Thia-3-aza-2-silacyclopentane,2,5-dimethyl-2-(p-fluorophenyl)-
| 84260-41-3 |
1-Thia-3-aza-2-silacyclopentane,2,5-dimethyl-2-(p-methoxyphenyl)-
| 84260-39-9 |
1-Thia-3-aza-2-silacyclopentane,2,5-dimethyl-2-phenyl-
| 84260-31-1 |
1-Thia-3-aza-2-silacyclopentane, 2,2-diphenyl-
| 84260-35-5 |
1-Thia-3-aza-2-silacyclopentane,2-(p-fluorophenyl)-2-methyl-
| 84260-27-5 |
1-Thia-3-aza-2-silacyclopentane,2-(p-methoxyphenyl)-2-methyl-
| 84260-25-3 |
1-Thia-3-aza-2-silacyclopentane, 2-methyl-2-phenyl-
| 84260-23-1 |
1-Thia-3-aza-2-silacyclopentane,2-methyl-2-(p-tolyl)-
| 84260-37-7 |
1-Thia-4-azaspiro(4.5)decane, 8-methyl-,hydrochloride
| 31404-04-3 |
2-Thia-7-azaspiro(4.4)nonane-6,8-dione, 7-allyl-
| 10288-31-0 |
3-Thenylamine, 2-bromo-N,N-bis(2-chloroethyl)-,hydrochloride
| 13792-99-9 |
7-Thiabicyclo(2.2.1)heptane-2,3-dicarboxylic acid,(exo,exo)-
| 109282-39-5 |
9-Thiabicyclo(3.3.1)nonane, 2,6-dichloro-
| 6522-21-0 |
8-Thia-1,3-diazaspiro(4.5)decane-2,4-dione
| 39124-15-7 |
|
|